Used primarily in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly kinase inhibitors. Its structure supports the development of agents targeting inflammatory diseases, cancer, and central nervous system disorders. The compound's fused heterocyclic core enhances binding affinity to specific enzyme targets, making it valuable in structure-activity relationship (SAR) studies. It is also employed in the preparation of selective modulators for adenosine receptors and phosphodiesterases, contributing to drug discovery efforts in neurodegeneration and immune regulation.